We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Invasive Infections in Children With Hemoglobinopathies

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00456443
First Posted: April 5, 2007
Last Update Posted: July 25, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
HaEmek Medical Center, Israel
April 4, 2007
April 5, 2007
July 25, 2007
January 2006
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Invasive Infections in Children With Hemoglobinopathies
Invasive Infections in Children With Hemoglobinopathies. A Clinical Descriptive Retrospective Study.
Patients diagnosed as having hemoglobinopathies are exposed to serious bacterial infections, principally those patients that underwent splenectomy. Since the introduction of anti pneumococcal vaccine the incidence decreased significantly but other bacteria besides encapsulated bacteria takes place as principal cause of invasive infections. The purpose of this study is to analyse in a retrospective study the incidence of those infections in a group of patients suffering from thalassemia and sickle cell anemia treated in our clinic.
Not Provided
Observational
Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Cross-Sectional
Time Perspective: Retrospective
Not Provided
Not Provided
Not Provided
Not Provided
  • Thalassemia
  • Sickle Cell Anemia
Procedure: Historical records
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
200
June 2006
Not Provided

Inclusion Criteria:

  • All patients treated in the Pediatric Hematology Unit.
Sexes Eligible for Study: All
up to 40 Years   (Child, Adult)
No
Contact information is only displayed when the study is recruiting subjects
Israel
 
 
NCT00456443
4140905.EMC
No
Not Provided
Not Provided
Not Provided
HaEmek Medical Center, Israel
Not Provided
Study Director: Ariel Koren, MD Pediatric Hematology Unit, Ha'Emek Medical Center
Principal Investigator: Waheeb Sakran, MD Pediatric Dpt B - Ha'Emek Medical Center
HaEmek Medical Center, Israel
April 2007